Amneal Pharmaceuticals Other Long Term Liabilities (Quarterly) Trends

Amneal Pharmaceuticals, Inc. (AMRX)

14.53 +0.03 (+0.21%) USD | NASDAQ | Feb 23, 09:58

View Other Long Term Liabilities (Quarterly) for AMRX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Corcept Therapeutics, Inc.	--
Pfizer Inc.	Upgrade
Apellis Pharmaceuticals, Inc.	Upgrade
Nektar Therapeutics	Upgrade
Innoviva, Inc.	--